184 results
8-K
EX-10.1
MBOT
Microbot Medical Inc
4 Jun 24
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:35pm
8-K
EX-10.1
MBOT
Microbot Medical Inc
30 Jan 24
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
7:20am
8-K
EX-10.2
MBOT
Microbot Medical Inc
30 Jan 24
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
7:20am
S-1/A
EX-10.32
MBOT
Microbot Medical Inc
IPO registration (amended)
22 Jan 24
5:20pm
8-K
EX-10.1
MBOT
Microbot Medical Inc
2 Jan 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
9c9sx75o
21 Nov 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.1
se0ha
28 Jun 23
Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
6:13pm
8-K
EX-10.1
erenirlzi482
6 Jun 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-10.1
d3wokx2hcokyoql
24 May 23
Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:32pm
8-K
EX-10.2
zs09e
24 May 23
Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:32pm
8-K
EX-10.1
3y4irb
23 May 23
Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-10.1
izc5wfevknbnho
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
EX-10.4
um4126nupl1t82stsoic
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
EX-10.2
h9l9sp
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
EX-10.3
3daw8 nxojp
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
EX-10.1
u2nnc7
25 Oct 22
Microbot Medical Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:00pm
8-K
EX-10.1
cjldsmts1f kaf111xcl
7 Oct 22
Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices
8:59am
8-K
EX-10.1
ti3usvnvx3bp 03hq
6 Apr 22
Microbot Medical Continues to Strengthen Management Team as Rachel Vaknin Promoted to Chief Financial Officer
4:05pm
8-K
EX-10.1
uwy1qkww0byz7
1 Feb 22
Departure of Directors or Certain Officers
4:30pm